Zydus Worldwide DMCC and South Korea-based Daewoong Pharmaceutical on Monday (December 11, 2023) announced that they have entered an exclusive licensing agreement to co-develop and commercialise Leuprolide Acetate for Depot Suspension in six dosage strengths for the US market. The announcement was made through an exchange filing. As per the agreement, Zydus will assume full […]

About Tag: Leuprolide Acetate